Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck

Brian R. Gastman*, Jonathan S. Zager, Jane L. Messina, Robert W. Cook, Kyle R. Covington, Brooke Middlebrook, Pedram Gerami, Jeffrey D. Wayne, Sancy Leachman, John T. Vetto

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: We report the performance of a gene expression profile test to classify the recurrence risk of cutaneous melanoma tumors of the head and neck as low-risk Class 1 or high-risk Class 2. Methods: Of note, 157 primary head and neck cutaneous melanoma tumors were identified. Survival analyses were performed using Kaplan-Meier and Cox methods. Results: Gene expression profile class and node status stratified tumors into significantly different 5-year survival groups by Kaplan-Meier method (P <.0001 for all end points), and both were independent predictors of recurrence in multivariate analysis. Overall, 74% of distant metastases and 88% of melanoma-specific deaths had Class 2 risk. Conclusion: The gene expression profile test identifies cases at increased risk for metastasis and death independent of a clinically or pathologically negative nodal status, suggesting that incorporation of this molecular tool could improve clinical management of patients with head and neck cutaneous melanoma, especially in those with a negative sentinel lymph node biopsy.

Original languageEnglish (US)
Pages (from-to)871-879
Number of pages9
JournalHead and Neck
Volume41
Issue number4
DOIs
StatePublished - Apr 2019

Fingerprint

Transcriptome
Melanoma
Neck
Head
Skin
Neoplasm Metastasis
Recurrence
Sentinel Lymph Node Biopsy
Neoplasms
Survival Analysis
Multivariate Analysis
Survival

Keywords

  • cutaneous melanoma
  • gene expression profiling
  • metastasis
  • prognosis
  • staging

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Gastman, B. R., Zager, J. S., Messina, J. L., Cook, R. W., Covington, K. R., Middlebrook, B., ... Vetto, J. T. (2019). Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck. Head and Neck, 41(4), 871-879. https://doi.org/10.1002/hed.25473
Gastman, Brian R. ; Zager, Jonathan S. ; Messina, Jane L. ; Cook, Robert W. ; Covington, Kyle R. ; Middlebrook, Brooke ; Gerami, Pedram ; Wayne, Jeffrey D. ; Leachman, Sancy ; Vetto, John T. / Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck. In: Head and Neck. 2019 ; Vol. 41, No. 4. pp. 871-879.
@article{ffca90999e90405a93b21d2bdb7e57f0,
title = "Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck",
abstract = "Background: We report the performance of a gene expression profile test to classify the recurrence risk of cutaneous melanoma tumors of the head and neck as low-risk Class 1 or high-risk Class 2. Methods: Of note, 157 primary head and neck cutaneous melanoma tumors were identified. Survival analyses were performed using Kaplan-Meier and Cox methods. Results: Gene expression profile class and node status stratified tumors into significantly different 5-year survival groups by Kaplan-Meier method (P <.0001 for all end points), and both were independent predictors of recurrence in multivariate analysis. Overall, 74{\%} of distant metastases and 88{\%} of melanoma-specific deaths had Class 2 risk. Conclusion: The gene expression profile test identifies cases at increased risk for metastasis and death independent of a clinically or pathologically negative nodal status, suggesting that incorporation of this molecular tool could improve clinical management of patients with head and neck cutaneous melanoma, especially in those with a negative sentinel lymph node biopsy.",
keywords = "cutaneous melanoma, gene expression profiling, metastasis, prognosis, staging",
author = "Gastman, {Brian R.} and Zager, {Jonathan S.} and Messina, {Jane L.} and Cook, {Robert W.} and Covington, {Kyle R.} and Brooke Middlebrook and Pedram Gerami and Wayne, {Jeffrey D.} and Sancy Leachman and Vetto, {John T.}",
year = "2019",
month = "4",
doi = "10.1002/hed.25473",
language = "English (US)",
volume = "41",
pages = "871--879",
journal = "Head and Neck Surgery",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Gastman, BR, Zager, JS, Messina, JL, Cook, RW, Covington, KR, Middlebrook, B, Gerami, P, Wayne, JD, Leachman, S & Vetto, JT 2019, 'Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck', Head and Neck, vol. 41, no. 4, pp. 871-879. https://doi.org/10.1002/hed.25473

Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck. / Gastman, Brian R.; Zager, Jonathan S.; Messina, Jane L.; Cook, Robert W.; Covington, Kyle R.; Middlebrook, Brooke; Gerami, Pedram; Wayne, Jeffrey D.; Leachman, Sancy; Vetto, John T.

In: Head and Neck, Vol. 41, No. 4, 04.2019, p. 871-879.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck

AU - Gastman, Brian R.

AU - Zager, Jonathan S.

AU - Messina, Jane L.

AU - Cook, Robert W.

AU - Covington, Kyle R.

AU - Middlebrook, Brooke

AU - Gerami, Pedram

AU - Wayne, Jeffrey D.

AU - Leachman, Sancy

AU - Vetto, John T.

PY - 2019/4

Y1 - 2019/4

N2 - Background: We report the performance of a gene expression profile test to classify the recurrence risk of cutaneous melanoma tumors of the head and neck as low-risk Class 1 or high-risk Class 2. Methods: Of note, 157 primary head and neck cutaneous melanoma tumors were identified. Survival analyses were performed using Kaplan-Meier and Cox methods. Results: Gene expression profile class and node status stratified tumors into significantly different 5-year survival groups by Kaplan-Meier method (P <.0001 for all end points), and both were independent predictors of recurrence in multivariate analysis. Overall, 74% of distant metastases and 88% of melanoma-specific deaths had Class 2 risk. Conclusion: The gene expression profile test identifies cases at increased risk for metastasis and death independent of a clinically or pathologically negative nodal status, suggesting that incorporation of this molecular tool could improve clinical management of patients with head and neck cutaneous melanoma, especially in those with a negative sentinel lymph node biopsy.

AB - Background: We report the performance of a gene expression profile test to classify the recurrence risk of cutaneous melanoma tumors of the head and neck as low-risk Class 1 or high-risk Class 2. Methods: Of note, 157 primary head and neck cutaneous melanoma tumors were identified. Survival analyses were performed using Kaplan-Meier and Cox methods. Results: Gene expression profile class and node status stratified tumors into significantly different 5-year survival groups by Kaplan-Meier method (P <.0001 for all end points), and both were independent predictors of recurrence in multivariate analysis. Overall, 74% of distant metastases and 88% of melanoma-specific deaths had Class 2 risk. Conclusion: The gene expression profile test identifies cases at increased risk for metastasis and death independent of a clinically or pathologically negative nodal status, suggesting that incorporation of this molecular tool could improve clinical management of patients with head and neck cutaneous melanoma, especially in those with a negative sentinel lymph node biopsy.

KW - cutaneous melanoma

KW - gene expression profiling

KW - metastasis

KW - prognosis

KW - staging

UR - http://www.scopus.com/inward/record.url?scp=85060795056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060795056&partnerID=8YFLogxK

U2 - 10.1002/hed.25473

DO - 10.1002/hed.25473

M3 - Article

C2 - 30694001

AN - SCOPUS:85060795056

VL - 41

SP - 871

EP - 879

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 1043-3074

IS - 4

ER -

Gastman BR, Zager JS, Messina JL, Cook RW, Covington KR, Middlebrook B et al. Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck. Head and Neck. 2019 Apr;41(4):871-879. https://doi.org/10.1002/hed.25473